Ftse Mib
33.766,29
-0,06%
DAX
19.884,75
-0,57%
S&P 500
5.930,85
1,09%
NASDAQ
19.572,60
1,03%
Bitcoin
97.103,34
-0,11%
Pepperstone
Advertisement
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NYSE Arcus Biosciences Inc (RCUS) Arcus Biosciences Inc (RCUS) Notizie

Arcus Biosciences Inc

RCUS
15,09
-0,37 (-2,39%)
21 Dic 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NYSE
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
20/12/202422:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/12/202422:05BWArcus Biosciences to Participate in the 43rd Annual J.P...
18/12/202402:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/12/202402:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/12/202402:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/12/202422:35BWArcus Biosciences Announces New Employment Inducement Grants
04/12/202422:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/12/202422:35BWArcus Biosciences Announces New Employment Inducement Grants
19/11/202422:05BWArcus Biosciences to Participate in Two Upcoming Investor..
12/11/202422:35BWArcus Biosciences Announces New Employment Inducement Grants
08/11/202423:31EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
06/11/202422:25EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/11/202422:23EDGAR2Form 8-K - Current report
06/11/202422:22BWArcus Biosciences Reports Third-Quarter 2024 Financial..
05/11/202415:00BWArcus Biosciences Announces that Domvanalimab Plus..
30/10/202414:00BWArcus Biosciences to Present New Data for Anti-TIGIT..
24/10/202422:35BWArcus Biosciences Announces New Employment Inducement Grants
24/10/202422:11EDGAR2Form 8-K - Current report
24/10/202413:30BWFirst Clinical Data for Arcus Biosciences’ HIF-2a Inhibitor,..
22/10/202422:05BWArcus Biosciences to Host Conference Call to Discuss..
09/10/202422:35BWArcus Biosciences Announces New Employment Inducement Grants
09/10/202414:00BWArcus Biosciences to Present First Clinical Data from ARC-20..
02/10/202422:05BWArcus Biosciences Announces Clinical Trial Collaboration..
24/9/202422:35BWArcus Biosciences Announces New Employment Inducement Grants
18/9/202400:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/9/202422:35BWArcus Biosciences Announces New Employment Inducement Grants
27/8/202422:12EDGAR2Form 8-K - Current report
27/8/202422:05BWArcus Biosciences Secures Up to $250 Million Term Loan..
26/8/202422:35BWArcus Biosciences Announces New Employment Inducement Grants
21/8/202422:05BWArcus Biosciences to Participate in Two Upcoming Investor..
15/8/202422:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/8/202422:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202422:09EDGAR2Form 8-K - Current report
08/8/202422:05BWArcus Biosciences Reports Second-Quarter 2024 Financial..
25/7/202422:05BWArcus Biosciences to Host Conference Call to Discuss..
09/7/202422:35BWArcus Biosciences Announces New Employment Inducement Grants
09/7/202400:00BWTaiho Pharmaceutical Exercises Option for an Exclusive..
25/6/202422:35BWArcus Biosciences Announces New Employment Inducement Grants
18/6/202422:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/6/202422:35BWArcus Biosciences Announces New Employment Inducement Grants
10/6/202414:30BWArcus Biosciences Completes Patient Enrollment in Phase 3..
08/6/202400:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/6/202400:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/6/202400:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/6/202422:28EDGAR2Form 8-K - Current report
06/6/202422:05BWArcus Biosciences to Participate in the Goldman Sachs 45th..
03/6/202414:18EDGAR2Form 8-K - Current report
02/6/202414:00BWGilead and Arcus Announce Etrumadenant Plus Zimberelimab..
01/6/202414:00BWGilead and Arcus Announce Anti-TIGIT Domvanalimab Plus..
24/5/202422:35BWArcus Biosciences Announces New Employment Inducement Grants
Apertura: 15,11 Min: 15,10 Max: 15,99
Chiusura: 15,46

La tua Cronologia

NYSE
RCUS
Arcus Biosciences
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network